Skip to content

Clinical trials

Phase 3 Pulmonary Arterial Hypertension trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Phase: Phase 3 Clear all

104 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20035
20044
20053
20065
20073
200810
20094
20105
20117
20124
20137
20143
20153
20165
20174
20185
20195
20201
20215
20224
20232
20243
20251
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed56
Terminated21
Recruiting9
Withdrawn8
Active, not recruiting5
Not yet recruiting2
Unknown status2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion30
United Therapeutics14
Novartis Pharmaceuticals5
Gilead Sciences4
Pfizer4
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA3
Bayer3
Bellerophon Pulse Technologies3
Liquidia Technologies, Inc.3
Lung Biotechnology PBC3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension104
Hypertension, Pulmonary31
Hypertension7
Cardiovascular Diseases5
Connective Tissue Diseases5
Familial Primary Pulmonary Hypertension5
Eisenmenger Complex3
Lung Diseases3
Respiratory Tract Diseases3
Vascular Diseases3

Trials

Showing 51 to 75 of 104. Each trial links to its page on Pharma Observatory.

4 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.